Omaima M Sabek

Dr. Omaima M Sabek

orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2009 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
CWChristy M. Wilson
Christy M. Wilson
MGM. Waleed Gaber
M. Waleed Gaber
OSOmaima M Sabek
Omaima M Sabek
JZJanice A. Zawaski
Janice A. Zawaski
TMThomas E. Merchant
Thomas E. Merchant

1 May 2003 in International Journal of Radiation Biology
Verified
Journal Article
Closed access
MGM. W. Gaber
M. W. Gaber
OSOmaima M Sabek
Omaima M Sabek
KFK. Fukatsu
K. Fukatsu
HWH. G. Wilcox
H. G. Wilcox
MKM. F. Kiani
M. F. Kiani
TMT. E. Merchant
T. E. Merchant
Purpose: To elucidate the brain molecular response to irradiation. The expression of the intercellular adhesion molecule (ICAM‐1) and tumour necrosis factor‐α (TNF‐α) in the mouse brain was compared after single‐dose and fractionated whole‐brain irradiation. Materials and methods: Mice received a single dose of 2, 10 or 20 Gy or a fractionated dose (2 Gy day−1) of 10, 20 or 40 Gy. ICAM‐1, and TNF‐α mRNA expression were quantified by the highly sensitive real‐time polymerase chain reaction technique. Expression of ICAM‐1 protein was quantified by dual‐labelled monoclonal antibody assay. Results: After a 20‐Gy single dose, there was an increase in ICAM‐1 and TNF‐α mRNA levels (14‐ and 11‐fold, respectively) as well as a significant increase in the level of ICAM‐1 protein (p=0.0243). The expression of ICAM‐1 and TNF‐α mRNA increased at the end of the 40‐Gy fractionated regimen (3.55‐ and 2.30‐fold, respectively). Conclusions: The molecular response of the brain to single‐dose irradiation was rapid, while its response to fractionated irradiation was slow. This finding is consistent with clinical observations and could be of use when designing strategies to mitigate radiation sequelae.

1 September 2002 in Transplantation
Verified
Journal Article
Closed access
OSOmaima M Sabek
Omaima M Sabek
MDM. Tevfik Dorak
M. Tevfik Dorak
MKMalak Kotb
Malak Kotb
AGA. Osama Gaber
A. Osama Gaber
LGLillian Gaber
Lillian Gaber
The quest for noninvasive methods to diagnose rejection in solid-organ transplants has been rejuvenated by recent observations that specific cytotoxic T-cell markers are up-regulated during rejection. We developed a one-step real-time polymerase chain reaction (PCR) method allowing reliable detection of the expression of several T-cell genes within a relatively short period of time. The assay is highly sensitive and reproducible with a wide dynamic range allowing accurate quantification of target mRNA in as little as 3 pg total RNA. The utility of this assay in detecting renal allograft rejection was evaluated. Peripheral blood mononuclear cells were collected from 27 patients undergoing kidney allograft biopsies for renal dysfunction after transplantation. Expression of the T-cell activation markers, granzyme B, perforin, and HLA-DRA, was quantified and correlated to the histopathologic changes in the renal biopsies. In cases with allograft rejection (n=8), peripheral lymphocyte expression was increased for granzyme B (P <0.001) and perforin (P <0.08) compared with cases without rejection (n=19). Granzyme B mRNA up-regulation showed the highest specificity for detecting rejection (95%). Moreover, HLA-DRA mRNA was significantly up-regulated (P <0.0016) and had the highest sensitivity (88%) detecting rejection. The up-regulation of both granzyme B and HLA-DRA was most specific in detecting rejection, P <0.001. These data demonstrate that a rapid test of target gene up-regulation using real-time PCR can be used as an aid in the diagnosis of kidney allograft rejection. This is also the first report on the possible utility of HLA-DRA mRNA up-regulation as a marker for kidney transplant rejection.

1 August 2017 in Journal of Experimental Medicine
Verified
Journal Article
Open access
Abhisek MukherjeeAbhisek Mukherjee
Abhisek Mukherjee
DMDiego Morales-Scheihing
Diego Morales-Scheihing
NSNatalia Salvadores
Natalia Salvadores
Ines Moreno-GonzalezInes Moreno-Gonzalez
Ines Moreno-Gonzalez
CGCesar Gonzalez
Cesar Gonzalez
Claudio SotoClaudio Soto
Claudio Soto
Although a large proportion of patients with type 2 diabetes (T2D) accumulate misfolded aggregates composed of the islet amyloid polypeptide (IAPP), its role in the disease is unknown. Here, we show that pancreatic IAPP aggregates can promote the misfolding and aggregation of endogenous IAPP in islet cultures obtained from transgenic mouse or healthy human pancreas. Islet homogenates immunodepleted with anti-IAPP–specific antibodies were not able to induce IAPP aggregation. Importantly, intraperitoneal inoculation of pancreatic homogenates containing IAPP aggregates into transgenic mice expressing human IAPP dramatically accelerates IAPP amyloid deposition, which was accompanied by clinical abnormalities typical of T2D, including hyperglycemia, impaired glucose tolerance, and a substantial reduction on β cell number and mass. Finally, induction of IAPP deposition and diabetic abnormalities were also induced in vivo by administration of IAPP aggregates prepared in vitro using pure, synthetic IAPP. Our findings suggest that some of the pathologic and clinical alterations of T2D might be transmissible through a similar mechanism by which prions propagate in prion diseases.

23 August 2017 in Biotechnology Journal
Verified
Journal Article
Closed access
PDF file
MFMarco Farina
Marco Farina
ABAndrea Ballerini
Andrea Ballerini
DFDaniel W. Fraga
Daniel W. Fraga
ENEugenia Nicolov
Eugenia Nicolov
MHMatthew Hogan
Matthew Hogan
Alessandro GrattoniAlessandro Grattoni
Alessandro Grattoni

1 September 2015 in Endocrinology
Verified
Journal Article
Closed access
OSOmaima M Sabek
Omaima M Sabek
SNSatoru Ken Nishimoto
Satoru Ken Nishimoto
DFDaniel Fraga
Daniel Fraga
NTNeelam Tejpal
Neelam Tejpal
Camillo  RicordiCamillo Ricordi
Camillo Ricordi
AGA. O. Gaber
A. O. Gaber
The osteoblast-specific hormone osteocalcin (OC) was found to regulate glucose metabolism, fat mass, and β-cell proliferation in mice. Here, we investigate the effect of decarboxylated OC (D-OC) on human β-cell function and mass in culture and in vivo using a Nonobese diabetic-severe combined immunodeficiency mouse model. We found that D-OC at dose ranges from 1.0 to 15 ng/mL significantly augmented insulin content and enhanced human β-cell proliferation of cultured human islets. This was paralleled by increased expression of sulfonylurea receptor protein; a marker of β-cell differentiation and a component of the insulin-secretory apparatus. Moreover, in a Nonobese diabetic-severe combined immunodeficiency mouse model, systemic administration of D-OC at 4.5-ng/h significantly augmented production of human insulin and C-peptide from the grafted human islets. Finally, histological staining of the human islet grafts showed that the improvement in the β-cell function was attributable to an increase in β-cell ...